Pharmacokinetics and Safety of RV521 Formulations

Clinical trial NCT04065698 · COMPLETED

Trial details

NCT number: NCT04065698
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2019-08-13
Primary completion: 2019-09-02
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.